Obviously, there is reduction in body weight, reduction in glucose levels, which may have contributed to a certain extent, but those alone do not explain the benefits that we are seeing
Because many GLP-1 therapies are prescribed to individuals with obesity or metabolic syndrome, separating medication effects from underlying risk factors can be difficult
At Harmony Aesthetics Spa, I use InBody scans to show real changes, even when weight stalls
Adding the correct volume of bacteriostatic water, mixing gently without shaking (which denatures the protein), and storing at 28C immediately after mixing
The data suggest that GLP-1s do not increase the risk of cancer and may even reduce the risk of several types of cancer, particularly in people with obesity or Type 2 diabetes
Diabetologia 47: 926936, 2004